Aurobindo Pharma Get FDA Nod for Marketing Nafcillin Injections in US

Hyderabad-based Aurobindo Pharma revealed that it has received an approval from the US Food and Drug Administration to market Nafcillin injections in the United States.

Nafcillin injections are used to treat infections caused by penicillinase-producing staphylococci bacteria. Aurobindo said that it has received approval for manufacturing the injections in 1g and 2g vials and in 10g/vial pharmacy bulk package.

Source: Medindia